LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 13 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 3. - Dataset (ID:20250)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Barasertib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 1520 | 4660 | 0.3265 | 0.1139 |
MDA-MB-231 | Barasertib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 1523 | 4660 | 0.3277 | 0.1159 |
MDA-MB-231 | Barasertib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 1541 | 4660 | 0.3327 | 0.1231 |
MDA-MB-231 | Barasertib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 1451 | 4660 | 0.3114 | 0.0866 |
MDA-MB-231 | Barasertib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 1444 | 4660 | 0.3109 | 0.0853 |
MDA-MB-231 | Barasertib | 10 | uM | LJP5 | 72 | hr | 1235 | 1397 | 4660 | 0.3003 | 0.0663 |
MDA-MB-231 | Vemurafenib | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4745 | 4660 | 1.0211 | 1.0230 |
MDA-MB-231 | Vemurafenib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4648 | 4660 | 0.9988 | 0.9996 |
MDA-MB-231 | Vemurafenib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4614 | 4660 | 0.9922 | 0.9928 |
MDA-MB-231 | Vemurafenib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4371 | 4660 | 0.9393 | 0.9359 |
MDA-MB-231 | Vemurafenib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 4224 | 4660 | 0.9066 | 0.9002 |
MDA-MB-231 | Vemurafenib | 10 | uM | LJP5 | 72 | hr | 1235 | 2280 | 4660 | 0.4894 | 0.3762 |
MDA-MB-231 | Enzastaurin | 0.04 | uM | LJP5 | 72 | hr | 1235 | 4685 | 4660 | 1.0065 | 1.0073 |
MDA-MB-231 | Enzastaurin | 0.12 | uM | LJP5 | 72 | hr | 1235 | 4878 | 4660 | 1.0475 | 1.0495 |
MDA-MB-231 | Enzastaurin | 0.37 | uM | LJP5 | 72 | hr | 1235 | 4829 | 4660 | 1.0378 | 1.0399 |
MDA-MB-231 | Enzastaurin | 1.11 | uM | LJP5 | 72 | hr | 1235 | 4883 | 4660 | 1.0496 | 1.0523 |
MDA-MB-231 | Enzastaurin | 3.33 | uM | LJP5 | 72 | hr | 1235 | 4809 | 4660 | 1.0325 | 1.0341 |
MDA-MB-231 | Enzastaurin | 10 | uM | LJP5 | 72 | hr | 1235 | 5177 | 4660 | 1.1109 | 1.1130 |
MDA-MB-231 | Palbociclib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 2837 | 4405 | 0.6438 | 0.5726 |
MDA-MB-231 | Palbociclib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 2570 | 4405 | 0.5834 | 0.4902 |
MDA-MB-231 | Palbociclib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 2272 | 4405 | 0.5162 | 0.3939 |
MDA-MB-231 | Palbociclib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 2231 | 4405 | 0.5062 | 0.3788 |
MDA-MB-231 | Palbociclib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 2077 | 4405 | 0.4721 | 0.3271 |
MDA-MB-231 | Palbociclib | 10 | uM | LJP6 | 72 | hr | 1235 | 1812 | 4405 | 0.4124 | 0.2330 |
MDA-MB-231 | PF562271 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 3875 | 4405 | 0.8803 | 0.8659 |